Trials / Available
AvailableNCT05356312
Glioblastoma and Individualized Therapies
Retrospective Analysis of Glioblastoma Patients With Immune Therapies
- Status
- Available
- Phase
- —
- Study type
- Expanded Access
- Enrollment
- —
- Sponsor
- Zentrum fur Humangenetik Tuebingen · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The treatment of patients with World Health Organization (WHO) grade 4 malignant glioma has not seen any significant breakthrough the past years. Following surgery and radio / chemotherapy patients still experience a very high recurrence risk and the prognosis is dismal. The investigators observed patients with grade IV malignant glioma receiving individualized treatment based on their molecular profile including fully personalized vaccines.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Vaccination | Personalized neoantigen vaccination |
Timeline
- First posted
- 2022-05-02
- Last updated
- 2024-03-01
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05356312. Inclusion in this directory is not an endorsement.